A series of new hires and investigations at the agency appear to focus on penalizing gender-affirming care for minors—and those who speak in favor of it.WiredVittoria ElliottApr 24, 2026The Federal Trade Commission appears to be targeting transgender rights, going beyond its usual ways of operating to do so, according to experts and federal employees who spoke to WIRED.Since July 2025, the agency has been gearing up to frame gender-affirming care for minors as a consumer-protection issue, in a move that a former FTC employee, who spoke to WIRED on the condition of anonymity due to fear of retaliation, described as “very strange.”“I think their end goal here is to be on the front page, being warriors for the Trump anti-trans agenda,” they claim.
Why? This is pure hatred.
“The FTC has brought lots of cases around phony cures, phony health products,” the former employee says. But those cases were targeted around issues like businesses peddling fake Covid cures. In cases where the FTC has gone after nonprofits, the former employee says, it has involved the nonprofit misappropriating donations.
Who will be the focus of all this? Doctors? Hospitals? The AMA and APA? This is a targeted attack on the trans community, and the official response from the agency to a news organization proves it:
The former FTC employee described the agency’s move to target nonprofits as “really weird” and said it was “very unusual” to hire lawyers for a specific project or case as opposed to recruiting people based on skill sets, like data protection.In response to questions from WIRED, FTC spokesperson Joseph Simonson said, “Virtually everything you asked is based off a complete misunderstanding of the law, this agency, and the issue of whether children are potentially suffering from unnecessary mutilation. Stick to computers.”
Contrast this rhetoric with the actual medical data. On the National Institutes of Health (NIH) website, specifically in the article "Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care," published in JAMA, the evidence is clear:
Conclusions and relevance: This study found that gender-affirming medical interventions were associated with lower odds of depression and suicidality over 12 months. These data add to existing evidence suggesting that gender-affirming care may be associated with improved well-being among TNB youths over a short period, which is important given mental health disparities experienced by this population, particularly the high levels of self-harm and suicide.
All the medical evidence shows that this treatment helps us, yet it is being ignored. Instead, the administration is relying on "evidence" from far-right medical organizations. The Wired article concludes by showing this is a coordinated effort across multiple departments:
Other agencies have also targeted trans rights. In July 2025, the Department of Justice subpoenaed doctors and clinics providing gender-related care for minors. “Medical professionals and organizations that mutilated children in the service of a warped ideology will be held accountable by this Department of Justice,” then-attorney general Pam Bondi said in a statement at the time. In December 2025, the Department of Health and Human Services announced that it would bar hospitals that accept Medicare and Medicaid from performing gender-affirming care. Earlier this month, a federal judge overturned the HHS ban, writing, “This case highlights a leader’s unserious regard for the rule of law.”
Naw... tell me again how there’s "no bias" here.
The Courthouse News reports that judges are seeing through this sham.
The Justice Department issued over 20 subpoenas to clinics providing gender-affirming care after Trump called for the end of such services.Monique MerrillMarch 6, 2026A battle over a subpoena targeting a Washington clinic that provides gender-affirming care to minors reached the Ninth Circuit on Friday, with the Trump administration arguing a judge wrongly blocked its investigation into drug manufacturers.“It just can’t be right that the administration must choose between advocating for a policy outcome and using tools like regulatory actions and proposing legislation to achieve that outcome on the one hand, and enforcing existing laws to protect consumers within the same space where it’s engaging in policy advocacy,” said Sarah Welch, attorney with the Department of Justice.The Justice Department issued a subpoena in June to QueerDoc, a telehealth clinic that provides gender-affirming care to adolescents and adults.The department sought records as part of an investigation into possible violations of the Federal Food, Drug, and Cosmetic Act by manufacturers of drugs used in gender-affirming care, including puberty blockers and hormone therapies.[...]In October, U.S. District Judge Jamal Whitehead quashed the subpoena, agreeing with QueerDoc that the Justice Department had weaponized its investigative authority to advance Trump’s policy goal of eliminating gender-affirming care.[...]But U.S. Circuit Judge Daniel Bress, a Donald Trump appointee, questioned why the Justice Department would need patient records.The Trump administration argued that it needed complete records to verify whether the medications QueerDoc prescribed matched the insurance billing and the patient’s diagnosis.QueerDoc contended that the Justice Department issued the subpoena under the guise of conducting an investigation but really issued it to advance Trump’s goal of ending gender-affirming care.
No way would Trump be trying to end our healthcare! (This is sarcasm.)
No comments:
Post a Comment